Le Lézard
Classified in: Health
Subjects: NPT, AVO

Amref Health Africa Staff Named to TIME 100


Kenyan Nice Nailantei Leng'ete on TIME's annual list of the world's most influential people

NEW YORK, April 19, 2018 /PRNewswire/ - Amref Health Africa's global CEO, Dr. Githinji Gitahi, today congratulated staff member Nice Nailantei Leng'ete on being named to TIME 100, TIME's annual list of the world's most influential people. Ms. Leng'ete received the honor for her work with Maasai communities in Kenya to end the practice of Female Genital Mutilation (FGM, also known as Female Genital Cutting or FGC).

"I have the privilege of knowing Nice and seeing how she is improving the lives of girls every day," said Dr. Githinji Gitahi, Group Chief Executive Officer, who is based at Amref Health Africa's international headquarters in Nairobi, Kenya. "She is an extraordinary young woman whose passion for the rights of girls is transforming social norms and practices so they can become the women they want to be."

Ms. Leng'ete was only 8 years old when she ran away from her home to avoid being subjected to FGM/C, a practice that was common for young girls in the village of Noomayianat, Kenya where she grew up. She endured beatings but still refused to undergo FGM/C. She eventually convinced her grandfather, a Maasai elder, to allow her not to have FGM/C so she could continue going to school. In many communities, like Ms. Leng'ete's, the practice of FGM/C is directly linked to child marriage and lack of education for girls.

In honor of Ms. Leng'ete's efforts to end FGM/C, and her inclusion in the TIME 100, Amref Health Africa is raising funds to give more girls in Africa an alternative. Donations can be made online at https://donate.amrefusa.org/EndFGM

Ms. Leng'ete will be attending the TIME 100 Gala in New York City on Tuesday, April 24, 2018.

"I personally have seen too many women and girls, too many friends, have their dreams taken away from them. Harmful practices have impacted their lives, and they can never get those days back. And this needs to change," says Ms. Leng'ete. "I'll continue to fight until no Maasai girl has to undergo FGM/C. I will continue to demand that girls can grow into women without being circumcised. Every young girl in Kenya can become the woman of her dreams. I am, for sure."

The World Health Organization defines FGM/C as "all procedures that involve partial or total removal of the external female genitalia, or other injury to the female genital organs for non-medical reasons."

SOURCE AMREF Canada (African Medical and Research Foundation)


These press releases may also interest you

at 05:15
The "Flow Cytometry Markets. Forecasts by Technology, Product and Application. With Executive and Consultant Guides. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. The technology is moving faster than the market. Find the...

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 05:00
Medical equipment manufacturing company Aohua Endoscopy clinched the Endoscopy Product Innovation Award at the recently held Healthcare Asia Medtech Awards 2024 for its development of the Aohua 4K AQ-300 video endoscopy system, which offers an...

at 03:52
The progressive decrease in hearing in elderly people can represent a major problem for their quality of life: it has in fact been demonstrated that critical issues such as these, in addition to being a problem as such, can...

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: